• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型和2型糖尿病确诊后十年的医疗保健使用情况及费用:一项基于人群的研究。

Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.

作者信息

Johnson Jeffrey A, Pohar Sheri L, Majumdar Sumit R

机构信息

Institute of Health Economics, 1200-10405 Jasper Ave., Edmonton, Alberta, Canada.

出版信息

Diabetes Care. 2006 Nov;29(11):2403-8. doi: 10.2337/dc06-0735.

DOI:10.2337/dc06-0735
PMID:17065675
Abstract

OBJECTIVE

To analyze trends in health care costs in the decade after identification of diabetes, contrasting type 1 and 2 diabetes.

RESEARCH DESIGN AND METHODS

The Canadian National Diabetes Surveillance System criteria were applied to administrative databases to identify incident diabetes cases in 1992. Cases were categorized as type 1 or type 2 diabetes based on patterns of drug use. Per capita health care costs (in 2001 Canadian dollars) for five resource categories were estimated according to the type of diabetes, for the year before identification (1991) and 10 years after (1992-2001) identification of the cases.

RESULTS

We identified 156 type 1 and 3,469 type 2 incident cases of diabetes, from a population base of approximately 950,000. The mean (+/-SD) age of case subjects at index was 61.2 +/- 16.7 years, and 54% of subjects were male. Overall annual per capita health expenditures rose considerably in the year after identification of diabetes but then stabilized at a lower level for the next 9 years, ranging from $3,800 to $4,400. From 1992 to 2001, diabetic individuals used $137.1 million in health care resources, most of which (96%) was attributable to type 2 diabetes. The average 10-year cost per individual with diabetes was $37,820 ($33,684 per type 1 and $38,006 per type 2 diabetes case; adjusted P = 0.45).

CONCLUSIONS

Total health expenditures for diabetes are driven by the much larger prevalence of type 2 compared with type 1 diabetes. Policymakers need to acknowledge and allocate resources for diabetes prevention and management accordingly.

摘要

目的

分析确诊糖尿病后十年内的医疗费用趋势,对比1型和2型糖尿病。

研究设计与方法

将加拿大国家糖尿病监测系统标准应用于行政数据库,以识别1992年的糖尿病新发病例。根据用药模式将病例分为1型或2型糖尿病。按照糖尿病类型,估算确诊前一年(1991年)和确诊后10年(1992 - 2001年)五个资源类别的人均医疗费用(以2001年加拿大元计)。

结果

我们从约95万人口基数中识别出156例1型糖尿病新发病例和3469例2型糖尿病新发病例。病例对象在索引时的平均(±标准差)年龄为61.2±16.7岁,54%的对象为男性。确诊糖尿病后的第一年,总体人均年度医疗支出大幅上升,但在接下来的9年稳定在较低水平,范围为3800美元至4400美元。1992年至2001年,糖尿病患者使用了1.371亿美元的医疗资源,其中大部分(96%)归因于2型糖尿病。糖尿病患者的人均10年平均费用为37820美元(1型糖尿病患者为33684美元,2型糖尿病患者为38006美元;校正P = 0.45)。

结论

与1型糖尿病相比,2型糖尿病的患病率高得多,推动了糖尿病的总体医疗支出。政策制定者需要认识到这一点,并相应地为糖尿病预防和管理分配资源。

相似文献

1
Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.1型和2型糖尿病确诊后十年的医疗保健使用情况及费用:一项基于人群的研究。
Diabetes Care. 2006 Nov;29(11):2403-8. doi: 10.2337/dc06-0735.
2
Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.加拿大城乡糖尿病患者的医疗保健费用与死亡率:1993年至2001年基于人群的趋势
Clin Ther. 2007 Jun;29(6 Pt 1):1316-24. doi: 10.1016/j.clinthera.2007.07.001.
3
Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.糖尿病的成本:疾病归因和匹配队列成本估算方法的比较。
Curr Med Res Opin. 2010 Aug;26(8):1827-34. doi: 10.1185/03007995.2010.488544.
4
The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.肥胖导致澳大利亚2型糖尿病成本上升:弗里曼特尔糖尿病研究的预测
Intern Med J. 2006 Mar;36(3):155-61. doi: 10.1111/j.1445-5994.2006.01014.x.
5
Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.对医疗补助计划糖尿病患者疾病直接成本和医疗保健利用情况的实证调查。
Am J Manag Care. 1998 Oct;4(10):1433-46.
6
Economic costs of diabetes in the U.S. In 2007.2007年美国糖尿病的经济成本。
Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017.
7
The cost of obesity in Canada.加拿大肥胖问题的代价。
CMAJ. 1999 Feb 23;160(4):483-8.
8
[Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].[德国青少年肥胖与2型糖尿病合并症:发展情况及疾病成本分析]
Gesundheitswesen. 2006 Oct;68(10):600-12. doi: 10.1055/s-2006-927181.
9
The economic burden of nephropathy in diabetic patients in Germany in 2002.2002年德国糖尿病患者肾病的经济负担。
Diabetes Res Clin Pract. 2008 Apr;80(1):34-9. doi: 10.1016/j.diabres.2007.11.012. Epub 2008 Jan 9.
10
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.瑞典2型糖尿病的资源利用与成本——基于人群登记数据的估计
Int J Clin Pract. 2008 May;62(5):708-16. doi: 10.1111/j.1742-1241.2008.01716.x. Epub 2008 Mar 17.

引用本文的文献

1
Versatile Nutraceutical Potentials of Watermelon-A Modest Fruit Loaded with Pharmaceutically Valuable Phytochemicals.西瓜的多功能营养潜力——一种含有药用价值植物化学物质的普通水果。
Molecules. 2020 Nov 11;25(22):5258. doi: 10.3390/molecules25225258.
2
Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada.利用电子病历和行政医疗保健数据验证1型糖尿病算法,以研究加拿大安大略省1型糖尿病的人群发病率和患病率。
BMJ Open Diabetes Res Care. 2020 Jun;8(1). doi: 10.1136/bmjdrc-2020-001224.
3
Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States.
美国 1 型糖尿病成人患者年度医疗保健费用估算。
J Manag Care Spec Pharm. 2020 Mar;26(3):311-318. doi: 10.18553/jmcp.2020.26.3.311.
4
Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data.2 型糖尿病对卫生支出的影响:基于个体行政数据的估计。
Eur J Health Econ. 2019 Jul;20(5):657-668. doi: 10.1007/s10198-018-1024-9. Epub 2019 Jan 5.
5
Trajectory of Excess Medical Expenditures 10 Years Before and After Diabetes Diagnosis Among U.S. Adults Aged 25-64 Years, 2001-2013.25-64 岁美国成年人糖尿病诊断前 10 年和后 10 年的过度医疗支出轨迹,2001-2013 年。
Diabetes Care. 2019 Jan;42(1):62-68. doi: 10.2337/dc17-2683. Epub 2018 Nov 19.
6
Temporal changes in diet quality and the associated economic burden in Canada.加拿大饮食质量的时间变化及相关经济负担。
PLoS One. 2018 Nov 8;13(11):e0206877. doi: 10.1371/journal.pone.0206877. eCollection 2018.
7
The economic burden of not meeting food recommendations in Canada: The cost of doing nothing.加拿大未能满足食品建议的经济负担:不作为的代价。
PLoS One. 2018 Apr 27;13(4):e0196333. doi: 10.1371/journal.pone.0196333. eCollection 2018.
8
The role of the Human Metabolome Database in inborn errors of metabolism.人代谢组数据库在先天性代谢缺陷中的作用。
J Inherit Metab Dis. 2018 May;41(3):329-336. doi: 10.1007/s10545-018-0137-8. Epub 2018 Apr 16.
9
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study.英国2型糖尿病的成本与治疗途径:一项策划群组研究
Diabetes Ther. 2017 Oct;8(5):1031-1045. doi: 10.1007/s13300-017-0296-x. Epub 2017 Sep 6.
10
The economic burden of inadequate consumption of vegetables and fruit in Canada.加拿大蔬菜和水果摄入不足带来的经济负担。
Public Health Nutr. 2017 Feb;20(3):515-523. doi: 10.1017/S1368980016002846. Epub 2016 Nov 7.